Evidence map›Paper›PMID 8932384›Full record

ArticleNucleic acids research1996

Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein.

G Farmer, P Friedlander, J Colgan, J L Manley, C Prives

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. p53 regulates Ki-67 promoter activity through p53- and Sp1-dependent manner in HeLa cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2011
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

G FarmerDepartment of Biological Sciences, Columbia University, New York, NY 10027, USA.
P Friedlander
J Colgan
J L Manley
C Prives
Columbia University · US

Funding

Regulation of the p53 tumor suppressor proteinR01CA058316 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI PRIVES, CAROL · 1993 to 2017
$5.3M
REGULATION OF THE P53 TUMOR SUPPRESSOR PROTEINR37CA058316 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI PRIVES, CAROL · 1998 to 2007
$3.8M
TRANSCRIPTIONAL CONTROL OF HOMEO BOX GENE EXPRESSIONR01GM037971 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI MANLEY, JAMES L. · 1987 to 2006
$1.8M
NCI NIH HHS CA58316NIGMS NIH HHS GM37971
6 · The paper itself

Abstract

In addition to serving a role as a DNA binding-dependent transcriptional activator, p53 has been reported to repress a variety of promoters that lack p53 binding sites. Data from recent studies have suggested that this activity is mediated via an interaction between p53 and the TATA box binding protein (TBP). To investigate the functional relevance of this interaction in vivo, we have performed transient transfection assays in Drosophila Schneider cells. Wild-type p53 was found to repress expression from TATA box- but not initiator (Inr)-containing promoters activated by GAL4-VP16, GAL4-ftzQ or Sp1. A mutant p53(His175), defective in DNA binding and transcriptional activation, also inhibited TATA-dependent transcription activated by Sp1. However, p53 was unable to repress a basal TATA promoter stimulated by overexpression of TBP. Furthermore, overexpression of TBP failed to rescue the p53-mediated repression of activated transcription and a p53 mutant with its N-terminal TBP interaction domain intact, but defective in transcriptional activation and binding to TBP-associated factors (TAFs), was similarly defective in transcriptional repression. These data suggest that a p53-TBP interaction is not sufficient for transcriptional repression by p53 and that repression involves an interaction between p53 and other factors, such as TAFs, that are required for activated but not basal transcription. We suggest that p53-mediated repression results from squelching of a factor limiting for activated transcription from TATA- but not Inr-containing promoters.

Indexed as

Gene Expression RegulationAnimalsCell LineChloramphenicol O-AcetyltransferaseDNA-Binding ProteinsDrosophilaHumansPromoter Regions, GeneticProtein BindingRecombinant ProteinsRepressor ProteinsTATA BoxTATA-Box Binding ProteinTranscription FactorsTranscription, GeneticTransfectionChloramphenicol O-AcetyltransferaseDNA-Binding ProteinsRecombinant ProteinsRepressor ProteinsTATA-Box Binding ProteinTranscription FactorsTumor Suppressor Protein p53

Identifiers

PMID8932384
PMCPMC146238
OpenAlexW2115986380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.